The U.S. marshals sent by the Food and Drug Administration seized some supplies of contaminated blood thinner containing material from China, from an Ohio company’s supplies. Eleven lots of heparin from Celsus Laboratories Inc. of Cincinnati were seized from the company that distributes heparin to drug and medical-device manufacturers both in the United States and internationally.
Mike Chappell, the FDA's acting associate commissioner for regulatory affairs said, "This action will help prevent this contaminated heparin from finding its way into the marketplace."